Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 207 | 6,918 | 8,379 | 8,377 | 17,456 |
| Cost of Goods | N/A | N/A | N/A | 54 | 4,506 |
| Gross Profit | 207 | 6,918 | 8,379 | 8,323 | 12,950 |
| Operating Expenses | 1,180 | 1,063 | 1,371 | 1,733 | 2,656 |
| Operating Income | -973 | 5,855 | 7,008 | 6,644 | 10,800 |
| Interest Expense | 0 | 6 | 0 | 0 | 0 |
| Pre-tax Income | -973 | 5,849 | 7,008 | 6,644 | 10,800 |
| Income Tax | 6 | N/A | 1,563 | 7,770 | -10,837 |
| Net Income Continuous | -979 | 5,849 | 5,445 | -1,126 | 21,637 |
| Net Income | $-979 | $5,849 | $5,445 | $-1,126 | $21,637 |
| EPS Basic Total Ops | -0.02 | 0.13 | 0.12 | -0.03 | 0.49 |
| EPS Basic Continuous Ops | -0.02 | 0.13 | 0.12 | -0.03 | 0.49 |
| EPS Diluted Total Ops | -0.02 | 0.13 | 0.12 | -0.03 | 0.49 |
| EPS Diluted Continuous Ops | -0.02 | 0.13 | 0.12 | -0.03 | 0.49 |
| EPS Diluted Before Non-Recurring Items | -0.02 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-973 | $5,855 | $7,008 | $6,644 | $10,800 |